Literature DB >> 16893499

The phenotypic characterization of naturally occurring regulatory CD4+CD25+ T cells.

Huanfa Yi1, Yu Zhen, Lingling Jiang, Jialin Zheng, Yong Zhao.   

Abstract

The homeostasis of the immune system depends on the balance between the immune response to an invaded pathogen and the immune tolerance to self antigens. Both central and peripheral tolerances are important mechanisms for the induction and maintenance of T cell tolerance. Recently, much attention has been paid to regulatory T cells (Treg), which play a significant role in maintaining peripheral immune tolerance. So far, there has been no satisfactory advance regarding the surface markers of Treg cells, as none is unique for Treg cells. In this review, we summarize some important molecules expressed in naturally occurring CD4+CD25+ Treg cells (nTreg), including forkhead/winged-helix family transcriptional repressor p3 (Foxp3), the tumor necrosis factor receptor (TNFR) family, CD28/CTLA4 molecules, chemokine receptors, Toll-like receptors (TLRs), membrane-bound TGF-beta and other molecules, such as neuropilin-1, lymphocyte activation gene-3 (LAG)-3 and granzyme. This review provides a collective view on current studies of nTreg cell activation and development related to the expression of molecules and cell phenotype markers, which is important for elucidation of nTreg cell origin, development and function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16893499

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  36 in total

Review 1.  Molecular and functional heterogeneity of T regulatory cells.

Authors:  Lequn Li; Vassiliki A Boussiotis
Journal:  Clin Immunol       Date:  2011-08-30       Impact factor: 3.969

2.  Physiologic control of IDO competence in splenic dendritic cells.

Authors:  Babak Baban; Phillip R Chandler; Burles A Johnson; Lei Huang; Minghui Li; Marlon L Sharpe; Loise M Francisco; Arlene H Sharpe; Bruce R Blazar; David H Munn; Andrew L Mellor
Journal:  J Immunol       Date:  2011-08-03       Impact factor: 5.422

Review 3.  The effects of immunosuppression on regulatory CD4(+)CD25(+) T cells: impact on immunosuppression selection in transplantation.

Authors:  Aqeel Javeed; Yong Zhao
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

4.  Characterization of human invariant natural killer T cells expressing FoxP3.

Authors:  Péter Engelmann; Klára Farkas; János Kis; Geoffrey Richman; Zhaoyun Zhang; Chong Wee Liew; Maciej Borowiec; Monika A Niewczas; Heyam Jalahej; Tihamér Orbán
Journal:  Int Immunol       Date:  2011-06-27       Impact factor: 4.823

Review 5.  Update on the immunological pathway of negative regulation in acute insults and sepsis.

Authors:  Ying-yi Luan; Yong-ming Yao; Zhi-yong Sheng
Journal:  J Interferon Cytokine Res       Date:  2012-04-17       Impact factor: 2.607

6.  CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients.

Authors:  Bülent Karagöz; Oğuz Bilgi; Mahmut Gümüs; Alev Akyol Erikçi; Ozkan Sayan; Orhan Türken; Emin Gökhan Kandemir; Ahmet Oztürk; Mustafa Yaylaci
Journal:  Med Oncol       Date:  2009-01-16       Impact factor: 3.064

Review 7.  How regulatory T cells work.

Authors:  Dario A A Vignali; Lauren W Collison; Creg J Workman
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

8.  Regulatory T cells and their role in rheumatic diseases: a potential target for novel therapeutic development.

Authors:  Diana Milojevic; Khoa D Nguyen; Diane Wara; Elizabeth D Mellins
Journal:  Pediatr Rheumatol Online J       Date:  2008-12-01       Impact factor: 3.054

9.  Cutting edge: regulatory T cells do not require stimulation through their TCR to suppress.

Authors:  Andrea L Szymczak-Workman; Creg J Workman; Dario A A Vignali
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

10.  Neuropilin-1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancer.

Authors:  Alessandra Battaglia; Alexia Buzzonetti; Giovanni Monego; Laura Peri; Gabriella Ferrandina; Francesco Fanfani; Giovanni Scambia; Andrea Fattorossi
Journal:  Immunology       Date:  2007-11-20       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.